Sign in
MP19-20 DISCRIMINATING CLINICALLY SIGNIFICANT PROSTATE CANCER WITH BIOMARKERS ACROSS DISCRETE PROSTATE SIZES: IS THE CLINICAL PERFORMANCE OF A 4KSCORE OR PSA-DENSITY DETERMINED BY GLAND SIZE?
Abstract   Peer reviewed

MP19-20 DISCRIMINATING CLINICALLY SIGNIFICANT PROSTATE CANCER WITH BIOMARKERS ACROSS DISCRETE PROSTATE SIZES: IS THE CLINICAL PERFORMANCE OF A 4KSCORE OR PSA-DENSITY DETERMINED BY GLAND SIZE?

Mark I. Sultan, James T. Gross, Vicky Tran, Johnny C. Wang, Michael A. Daneshvar, Grant M. Henning, David I. Lee, Gerald L. Andriole, Sannoj Punnen, Ramy F. Youssef, …
The Journal of urology, Vol.213(5S), p.e691
05/2025
DOI: 10.1097/01.JU.0001109948.41896.8a.20

View Online

Details

Metrics

1 Record Views
Logo image